UNCY
Unicycive Therapeutics Inc
4.60$
-1.9%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Unicycive Therapeutics Inc (UNCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -31 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -0.8 | -1.2 | -1.5 | -5.8 | -16 | -18 | -29 | -31 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | 0.4 | 0.6 | |
| – | 0.0 | 0.2 | 1.0 | 1.0 | 1.8 | 2.4 | 2.6 | |
| 0.2 | 0.6 | 0.8 | 3.9 | – | – | – | – | |
| 0.0 | 0.3 | -0.2 | -0.1 | 1.2 | -0.1 | -0.4 | -6.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -12 | |
| – | – | – | – | – | 0.9 | 1.1 | 0.0 | |
| 0.6 | 1.4 | 1.4 | 0.0 | 0.0 | – | – | – | |
| 0.8 | 1.2 | 1.4 | 22 | -0.5 | 28 | 45 | 46 | |
| 0.0 | 0.0 | 0.0 | 17 | -16 | 9.2 | 16 | 3.1 | |
| -0.8 | -1.2 | -1.5 | -5.8 | -16 | -18 | -29 | -31 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.